Bcl-2 family members as prognostic indicators in AML

Hematology

Volumn 7, Issue 1, 2002, Pages 21-31

  Irvine, Alexandra E ^a   McMullin, Mary F ^a   Ong, Yong Lee ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

AML; Apoptosis; Bcl 2; Prognosis

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; CANCER SURVIVAL; CHEMOSENSITIVITY; CYTOGENETICS; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LEUKEMIA REMISSION; MITOCHONDRION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 0036287209     PISSN: 10245340     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330290011838     Document Type: Review

References (124)

1. "Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics"
2. "Apoptosis: Cell death defined by caspase activation"
3. "Caspases and apoptosis-biology and terminology"
4. "Cell death beyond apoptosis"
5. "More than one way to go"
6. "Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death"
7. "A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial"
8. "The t(14;18) chromosome translocations involved in B-cell neoplasma result from mistakes in VDJ joining"
9. "Post-embryonic cell lineages of the nematode, Caenorhabditis elegans"
10. "Bcl-2 initiates a new category of oncogenes: Regulators of cell death"
11. "Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells"
12. "Expression of bcl-2 oncogene protein in malignant lymphomas, including Hodgkin's Disease and non-Hodgkin's lymphomas of T-cell phenotype"
13. "Expression of the bcl-2 oncogene protein is not specific for the t(14;18) chromosomal translocation"
14. "Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukaemia"
15. "BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax"
16. "The proto-oncogene bcl-2 and its role in regulating apoptosis"
17. "The bcl-2 protein family: Arbiters of cell survival"
18. "BH3 only proteins-essential initiators of apoptotic cell death"
19. "Death and Survival Signals determine active/inactive conformations of Pro-apoptotic BAX, BAD, and BID Molecules"
20. "BCL-2 family members and the mitochondria in apoptosis"
21. "Bcl-2 family: Regulators of cell death"
22. "Bcl-2 heterodimerizes in vivo with conserved homolog, bax, that accelerates programmed cell death"
23. "Checkpoints of duelling dimers foil death wishes"
24. "The Mitochondrial FOF1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammal cells"
25. "Insights into programmed cell death through structural biology"
26. "tBID, a membrane-targeted death ligand, oligomerises BAK to release cytochrome c"
27. "Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death"
28. "Mitochondria and apoptosis"
29. "Mitochondrion as a novel target of anticancer therapy"
30. "BID-dependent and BID-independent pathways for BAX insertion into mitochondria"
31. "Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells"
32. "Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis"
33. "Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation"
34. "The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis"
35. "Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked"
36. "Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32)"
37. "Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3"
38. "DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis"
39. "Mitochondrial control of nuclear apoptosis"
40. "Bcl-2 inhibits the mitochondrial release of an apoptogenic protease"
41. "Bax directly induces release of cytochrome c from isolated mitochondria"
42. L regulates the membrane potential and volume homeostasis of mitochondria"
43. "Programmed cell death regulation: Basic mechanisms and therapeutic opportunities"
44. "Cleavage of bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukaemia cells"
45. "Activation of the CPP32 protease in apoptosis induced by 1-b-D arabinofuranosylcytosine and other DNA-damaging agents"
46. "Apoptosis and resistance to daunorubicin in human leukaemic cells"
47. "Wild type p53 is not sufficient for serum starvation-induced apoptosis in cancer cells but accelerates apoptosis in sensitive cells"
48. "Clinical significance of CD95, bcl-2 and bax expression in adult de novo acute leukemia in context of p-glycoprotein function, maturational stage and cytogenetics"
49. "Cross resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)"
50. "Signalling defect in the activation of caspase-3 and PKC delta in human TUR leukaemia cells is associated with resistance to apoptosis"
51. "Apoptosis and the dilemma of cancer chemotherapy"
52. "Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukaemia"
53. "Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma"
54. "The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and bcl-2"
55. "Bcl-2 and the regulation of programmed cell death"
56. "Life, death, and the pursuit of apoptosis"
57. "Bcl-2 gene transfer increases relative resistance of S49.1 and WEH 17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs"
58. "Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line"
59. "Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis"
60. "Bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair"
61. "High levels of p26 bcl-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells"
62. "Bcl-2 family proteins: Regulators of chemoresistance in cancer"
63. "Bcl-2: Prevention of apoptosis as a mechanism of drug resistance"
64. "Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukaemic cells"
65. "Control of sensitivity to induction of apoptosis in myeloid leukaemic cells by differentiation and bcl-2 dependent and independent pathways"
66. "Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression"
67. "Effects of bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukaemic cells"
68. "Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells"
69. "Estrogen promotes chemotherapuetic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells"
70. "Regulation of bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor"
71. "The prognostic impact on bcl-2 protein expression in acute myelogenous leukemia varies with cytogenetics"
72. "Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the ARA-C sensitivity of leukemic stem cells"
73. "Expression of Bcl-2 related genes in normal and AML progenitors: Changes induced by chemotherapy and retinoic acid"
74. "Antisense oligonucleotides suppresses B-cell lymphoma growth in a SCID-hu mouse model"
75. "Regulation of chemoresistance by the bcl-2 oncoprotein in non Hodgkin's lymphoma and lymphocytic leukemia cell lines"
76. "Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C"
77. "Liposomal bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other anti-apoptotic proteins"
78. "Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL"
79. "High expression of bcl-2 protein in acute myeloid leukaemia cells is associated with poor response to chemotherapy"
80. "The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia"
81. "Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells"
82. "High bcl-2 expression in acute myeloid leukaemia cells correlates with CD34 positivity and complete remission rate"
83. "High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukaemia"
84. "Regulation of bcl-2 and cell death by all-trans retinoic acid in acute promyelocytic cells"
85. "Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression"
86. "Bcl-2 mediated tumorigenicity of a human T-lymphoid cell line: Synergy with Myc and inhibition by bcl-2 anti-sense"
87. "All-trans-retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may porolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases"
88. L and bax in the control of apoptosis by cytokines and dexamethasone"
89. L fails to inhibit apoptosis mediated by a novel retinoid"
90. "Bcl-2/bax: A rheostat that regulates an anti-oxidant pathway and cell death"
91. "Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia"
92. "Ratio of bcl-xshort to bcl-xlong is different in good- and poor-prognosis subsets of acute myeloid leukaemia"
93. "Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphoblastic leukaemia"
94. "Bcl-2 family members in childhood acute lymphoblastic leukemia: Relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome"
95. "Relapse in childhood ALL is associated with a decrease of the bax/bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo"
96. "Double identify for proteins of the bcl-2 family"
97. "Expression level of Bcl-2 determines anti- or proapoptotic function"
98. "Conversion of Bcl-2 to a Bax-like death effector by caspases"
99. "Involvement of bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis"
100. "Alphaviruses induce apoptosis in bcl-2-overexpressing cells: Evidence for a caspase-mediated, proteolytic inactivation of bcl-2"
101. L through caspase interaction"
102. "Signaling-2000 and beyond"
103. "Regulation of Bcl-2 phosphorylation and potential significance for leukemic cell chemoresistance"
104. "Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1"
105. "BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia"
106. "Unwinding the loop of Bcl-2 phosphorylation"
107. (L) and Bcl-2"
108. ""Loop" domain is necessary for raxol induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting raxol-induced cytosolic accumulation of cytochrome c and apoptosis"
109. "Bcl-2 phosphorylation required for anti-apoptosis function"
110. "Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl-2 protein"
111. "Bcl-2 is the guardian of microtubule integrity"
112. "Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid"
113. "Mutations in apoptosis genes: A pathogenetic factor for human disease"
114. "Hematopoietic malignancies demonstrate loss-of-function mutations of BAX"
115. "Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma"
116. "Microsatellite instability and frameshift mutations in BAX and transforming growth factor-β RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines"
117. "Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype"
118. "Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution"
119. "Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients"
120. "Multiple Bcl-2 family members demonstrate selective dimerisations with Bax"
121. "Serine-70 is one of the critical sites for drug induced Bcl-2 phosphorylation in cancer cells"
122. "Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway"
123. "Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene"
124. "Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma"